Preceptorship in Multiple Sclerosis
23-24 November 2026
Overview
The programme is designed to provide participants with an updated and comprehensive overview of contemporary multiple sclerosis management, from diagnosis and monitoring to treatment strategies and emerging research. Through interactive lectures, case-based discussions and direct exposure to CEMCAT’s multidisciplinary clinical and research environment, participants will gain practical insights into the challenges and opportunities of modern MS care.
The course also offers a unique opportunity to exchange experiences with internationally recognized experts and peers, fostering collaboration and professional development among the next generation of MS specialists.
Aim
The programme aims to provide practical tools for addressing real-world challenges in MS care, including differential diagnosis, progressive disease, risk mitigation strategies, patient-centred care, and treatment optimization. Furthermore, participants will be exposed to innovative approaches in biomarker research, artificial intelligence, and multidisciplinary management, while gaining first-hand experience of the clinical, research and educational model implemented at CEMCAT.
Addressed to
This course is aimed at young neurologists interested in multiple sclerosis.
Day 1: Monday, 23 November 2026
09:30 - 10:00
Welcome to the Multiple Sclerosis Preceptorship & Welcome to CEMCAT
Mar Tintoré, Neurologist, Cemcat_HUVH
10:00 - 10:40
Clinical diagnosis of MS: criteria and beyond
Georgina Arrambide, Neurologist, Cemcat_HUVH
10:40 - 11:20
MRI in MS diagnosis and monitoring
Alex Rovira, Neuroradiologist, IDI_HUVH
11:40 - 12:20
Progressive MS: Diagnosis to Therapy
Mar Tintoré, Neurologist, Cemcat_HUVH
12:20 - 13:00
PIRA and MS
Carmen Tur, Neurologist, Cemcat_HUVH
13:00 - 13:40
Risk Mitigation Strategies: Vaccines
Susana Otero, Epidemiologist, HUVH
14:40 - 15:20
Controversies: Discontinuation versus de-escalation versus maintenance treatment
René Carvajal, Neurologist, Cemcat_HUVH
15:20 - 16:40
Visit to the Centre: Outpatient clinics, Neurorehabilitation, Basic Research Lab
René Carvajal, Neurologist
MJ Arévalo, Neuropsychologist
Andrés Míguez, MS Principal Investigator
Day 2: Tuesday, 24 November 2026
09:30 - 10:10
The benefits of early initiation of high-efficacy therapy in MS
Xavier Montalban, Neurologist, Cemcat_HUVH
10:10 - 10:50
Prevention of MS or fluid biomarkers in MS
Manuel Comabella, Neurologist, Cemcat_HUVH
11:20 - 12:00
Shared decision making
Miguel Angel Robles, Nurse, Cemcat_HUVH
12:00 - 12:40
AI in MS
Carmen Tur, Neurologist, Cemcat_HUVH
12:40 - 13:10
Gender issues in MS: Pregnancy
Paula Tagliani, Neurologist, Cemcat_HUVH
14:10 - 15:10
Workshop: Clinical Cases in MS
Ana Zabalza, Alex Rovira, Neurologist, Neuroradiologists, Cemcat, IDI, HUVH
İpek Güngör Doğan, Department of Neurology, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, University of Health Sciences, Turkey
Bedriye Karaman, Associate Professor, neurologist, Ege University Faculty of Medicine, Izmir